Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

pSivida announces phase I data on sustained-release implant for osteoarthritis of the knee

Dec. 15, 2017

Phase IIb study of bimekizumab in ankylosing spondylitis meets primary objective

Dec. 15, 2017

FDA approves Xeljanz and Xeljanz XR for psoriatic arthritis

Dec. 15, 2017

Corbus Pharmaceuticals initiates phase III RESOLVE-1 trial testing anabasum

Dec. 15, 2017

FDA approves Pfizer's infliximab biosimilar Ixifi

Dec. 14, 2017

Phase III data show efficacy of LMWF-5A in severe knee osteoarthritis

Dec. 7, 2017

Glenmark Pharmaceuticals identifies new nuclear receptor ROR-gamma antagonists

Dec. 5, 2017

Taltz approved by FDA for psoriatic arthritis

Dec. 4, 2017

Biophytis cleared to begin SARA-INT trial of Sarconeos in Belgium

Dec. 4, 2017

ID Pharma submits CTN in Japan for DiscGenics' IDCT-001 clinical trial

Nov. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...